143 related articles for article (PubMed ID: 9712490)
41. Basal CD34(+) cell count predicts peripheral blood progenitor cell mobilization and collection in healthy donors after administration of granulocyte colony-stimulating factor.
de la Rubia J; Lorenzo JI; Torrabadella M; Marín P; Insunza A; Sanz MA
Haematologica; 2004 Dec; 89(12):1530-2. PubMed ID: 15590408
[TBL] [Abstract][Full Text] [Related]
42. Unusual adverse events following peripheral blood stem cell (PBSC) mobilisation using granulocyte colony stimulating factor (G-CSF) in healthy donors.
Hilbe W; Nussbaumer W; Bonatti H; Thaler J; Niederwieser D; Nachbaur D
Bone Marrow Transplant; 2000 Oct; 26(7):811-3. PubMed ID: 11042668
[TBL] [Abstract][Full Text] [Related]
43. Successful peripheral blood stem cell harvesting with granulocyte colony-stimulating factor alone after previous mobilization failure.
Lefrère F; Lévy V; Makke J; Audat F; Cavazzana-Calvo M; Micléa JM
Haematologica; 2004 Dec; 89(12):1532-4. PubMed ID: 15590409
[TBL] [Abstract][Full Text] [Related]
44. Predictive parameters for granulocyte colony-stimulating factor-induced peripheral blood stem cell mobilization.
Okano A; Ashihara E; Shimazaki C; Uchiyama H; Inaba T; Taniguchi K; Maekawa T; Taniwaki M
J Clin Apher; 2008; 23(6):171-7. PubMed ID: 18988229
[TBL] [Abstract][Full Text] [Related]
45. Second donation of granulocyte-colony-stimulating factor-mobilized peripheral blood progenitor cells: risk factors associated with a low yield of CD34+ cells.
Platzbecker U; Bornhäuser M; Zimmer K; Lerche L; Rutt C; Ehninger G; Hölig K
Transfusion; 2005 Jan; 45(1):11-5. PubMed ID: 15647012
[TBL] [Abstract][Full Text] [Related]
46. Use of G-CSF to mobilise PBSC in normal healthy donors--an international survey.
Cleaver SA; Goldman JM
Bone Marrow Transplant; 1998 Jun; 21 Suppl 3():S29-31. PubMed ID: 9712489
[TBL] [Abstract][Full Text] [Related]
47. Flt3 ligand and thrombopoietin serum levels during peripheral blood stem cell mobilization with chemotherapy and recombinant human glycosylated granulocyte colony-stimulating factor (rhu-G-CSF, lenograstim) and after high-dose chemotherapy.
Bojko P; Pawloski D; Stellberg W; Schröder JK; Seeber S
Ann Hematol; 2002 Sep; 81(9):522-8. PubMed ID: 12373354
[TBL] [Abstract][Full Text] [Related]
48. Granulocyte-colony stimulating factor administration to healthy individuals and persons with chronic neutropenia or cancer: an overview of safety considerations from the Research on Adverse Drug Events and Reports project.
Tigue CC; McKoy JM; Evens AM; Trifilio SM; Tallman MS; Bennett CL
Bone Marrow Transplant; 2007 Aug; 40(3):185-92. PubMed ID: 17563736
[TBL] [Abstract][Full Text] [Related]
49. [Collection of peripheral hematopoietic stem cells for transplantation from volunteer donors--siblings of the patients].
Mayer J; Korístek Z; Krahulová M; Pospísil Z; Doubek M; Klabusay M; Brychtová Y; Hoffová V; Cernanská J; Krejcí M; Vorlícek J
Vnitr Lek; 2001 Sep; 47 Suppl 1():15-28. PubMed ID: 11693058
[TBL] [Abstract][Full Text] [Related]
50. [Peripheral blood stem cell collection in pediatric malignancies: comparison between three mobilizing regimens].
De Pasquale MD; Cacchione A; Foco M; Gozzer M; Libera F; Soscia F; Ragni G; Cappelli C
Clin Ter; 2003; 154(5):305-9. PubMed ID: 14994920
[TBL] [Abstract][Full Text] [Related]
51. Stem cell mobilisation with 16 microg/kg vs 10 microg/kg of G-CSF for allogeneic transplantation in healthy donors.
Kröger N; Renges H; Sonnenberg S; Krüger W; Gutensohn K; Dielschneider T; Cortes-Dericks L; Zander AR
Bone Marrow Transplant; 2002 May; 29(9):727-30. PubMed ID: 12040468
[TBL] [Abstract][Full Text] [Related]
52. Phenotypic changes in neutrophil granulocytes of healthy donors after G-CSF administration.
Zarco MA; Ribera JM; Urbano-Ispizua A; Filella X; Arriols R; Martínez C; Feliu E; Montserrat E
Haematologica; 1999 Oct; 84(10):874-8. PubMed ID: 10509033
[TBL] [Abstract][Full Text] [Related]
53. Superior mobilisation of haematopoietic progenitor cells with glycosylated G-CSF in male but not female unrelated stem cell donors.
Fischer JC; Frick M; Wassmuth R; Platz A; Punzel M; Wernet P
Br J Haematol; 2005 Sep; 130(5):740-6. PubMed ID: 16115131
[TBL] [Abstract][Full Text] [Related]
54. [CD34+ cell dose and hematologic recovery in allogeneic peripheral blood stem cell transplantation].
Sawada H; Wake A; Yamasaki Y; Izumi Y
Rinsho Ketsueki; 2000 Jun; 41(6):500-6. PubMed ID: 10921350
[TBL] [Abstract][Full Text] [Related]
55. Comparison of marrow and blood cell yields from the same donors in a double-blind, randomized study of allogeneic marrow vs blood stem cell transplantation.
Singhal S; Powles R; Kulkarni S; Treleaven J; Sirohi B; Millar B; Shepherd V; Saso R; Rowland A; Long S; Cabral S; Horton C; Mehta J
Bone Marrow Transplant; 2000 Mar; 25(5):501-5. PubMed ID: 10713626
[TBL] [Abstract][Full Text] [Related]
56. Clinical impact of a new automated system employed for peripheral blood stem cell collection.
Del Fante C; Perotti C; Viarengo G; Bellotti L; Parisi C; Marchesi A; Tinelli C; Salvaneschi L
J Clin Apher; 2006 Dec; 21(4):227-32. PubMed ID: 16847939
[TBL] [Abstract][Full Text] [Related]
57. Peripheral blood progenitor cell mobilization with intermediate-dose cyclophosphamide, sequential granulocyte-macrophage-colony-stimulating factor and granulocyte-colony-stimulating factor, and scheduled commencement of leukapheresis in 225 patients undergoing autologous transplantation.
Bashey A; Donohue M; Liu L; Medina B; Corringham S; Ihasz A; Carrier E; Castro JE; Holman PR; Xu R; Law P; Ball ED; Lane TA
Transfusion; 2007 Nov; 47(11):2153-60. PubMed ID: 17958545
[TBL] [Abstract][Full Text] [Related]
58. Peripheral blood progenitor cell collections in cancer patients: analysis of factors affecting the yields.
Sautois B; Fraipont V; Baudoux E; Fassotte MF; Hermanne JP; Jérusalem G; Bours V; Bosquée L; Schaaf-Lafontaine N; Paulus JM; Sondag D; Fillet G; Beguin Y
Haematologica; 1999 Apr; 84(4):342-9. PubMed ID: 10190949
[TBL] [Abstract][Full Text] [Related]
59. [Methods of autologous peripheral blood stem cell (PBSC) mobilization in oncological and hematological patients].
Fregatova LM; Shavva SA; Platonova GG; Golovacheva AA; Afanas'ev BV
Vopr Onkol; 1999; 45(4):380-3. PubMed ID: 10532095
[TBL] [Abstract][Full Text] [Related]
60. [Determination of optimal time to second allogeneic peripheral blood stem cell harvest from healthy donors].
Chang YJ; Huo MR; Zhao XY; Huang XJ
Zhonghua Xue Ye Xue Za Zhi; 2009 Aug; 30(8):509-13. PubMed ID: 19954635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
